These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 6319452

  • 21. Serotonergic regulation of cortisol secretion in dogs.
    Barbieri C, Sala M, Bigatti G, Rauhe WG, Guffanti A, Diena A, Scorza D, Bevilacqua M, Norbiato G.
    Endocrinology; 1984 Aug; 115(2):748-51. PubMed ID: 6745178
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Dose-response relationships between plasma adrenocorticotropin (ACTH), cortisol, aldosterone, and 18-hydroxycorticosterone after injection of ACTH-(1-39) or human corticotropin-releasing hormone in man.
    Oelkers W, Boelke T, Bähr V.
    J Clin Endocrinol Metab; 1988 Jan; 66(1):181-6. PubMed ID: 2826525
    [Abstract] [Full Text] [Related]

  • 26. Hormonal responses to d- and d,l-fenfluramine in healthy human subjects.
    Coccaro EF, Kavoussi RJ, Cooper TB, Hauger RL.
    Neuropsychopharmacology; 1996 Dec; 15(6):595-607. PubMed ID: 8946434
    [Abstract] [Full Text] [Related]

  • 27. Multiple hormone responses to stimulation with dl-fenfluramine in patients with major depression before and after antidepressive treatment.
    Kasper S, Vieira A, Schmidt R, Richter P.
    Pharmacopsychiatry; 1990 Mar; 23(2):76-84. PubMed ID: 2339181
    [Abstract] [Full Text] [Related]

  • 28. Modification of adrenal function by the anti-serotonin agent cyproheptadine.
    Plonk J, Feldman J.
    J Clin Endocrinol Metab; 1976 Feb; 42(2):291-5. PubMed ID: 177441
    [Abstract] [Full Text] [Related]

  • 29. Analysis of the specificity of physostigmine stimulation of adrenocorticotropin in man.
    Lewis DA, Sherman BM, kathol RG.
    J Clin Endocrinol Metab; 1984 Mar; 58(3):570-3. PubMed ID: 6319456
    [Abstract] [Full Text] [Related]

  • 30. Human corticotropin-releasing factor in man: pharmacokinetic properties and dose-response of plasma adrenocorticotropin and cortisol secretion.
    Schürmeyer TH, Avgerinos PC, Gold PW, Gallucci WT, Tomai TP, Cutler GB, Loriaux DL, Chrousos GP.
    J Clin Endocrinol Metab; 1984 Dec; 59(6):1103-8. PubMed ID: 6092407
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Plasma prolactin, adrenocorticotrophic hormone and cortisol after administration of d-fenfluramine or placebo to healthy subjects.
    Gorard DA, Taylor TM, Medbak SH, Perry LA, Libby GW, Farthing MJ.
    Int Clin Psychopharmacol; 1993 Dec; 8(2):123-8. PubMed ID: 8393895
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Higher n-3 fatty acids are associated with more intense fenfluramine-induced ACTH and cortisol responses among cocaine-abusing men.
    Buydens-Branchey L, Branchey M, Hibbeln JR.
    Psychiatry Res; 2011 Aug 15; 188(3):422-7. PubMed ID: 21658782
    [Abstract] [Full Text] [Related]

  • 36. Beta-endorphin attenuates the serum cortisol response to exogenous adrenocorticotropin.
    Beyer HS, Parker L, Li CH, Stuart D, Sharp BM.
    J Clin Endocrinol Metab; 1986 May 15; 62(5):808-11. PubMed ID: 3007553
    [Abstract] [Full Text] [Related]

  • 37. Stimulation by peptide histidine methionine (PHM) of adrenocorticotropin secretion in patients with Cushing's disease: a comparison with the effect of vasoactive intestinal peptide (VIP) and a study on the effect of combined administration of corticotropin-releasing hormone with PHM or VIP.
    Watanobe H, Tamura T.
    J Clin Endocrinol Metab; 1994 Jun 15; 78(6):1372-7. PubMed ID: 8200939
    [Abstract] [Full Text] [Related]

  • 38. Neuroendocrine and behavioral responses to challenge with the indirect serotonin agonist dl-fenfluramine in adults with obsessive-compulsive disorder.
    McBride PA, DeMeo MD, Sweeney JA, Halper J, Mann JJ, Shear MK.
    Biol Psychiatry; 1992 Jan 01; 31(1):19-34. PubMed ID: 1311964
    [Abstract] [Full Text] [Related]

  • 39. The antiglucocorticoid and antiprogestin steroid RU 486 suppresses the adrenocorticotropin response to ovine corticotropin releasing hormone in man.
    Laue L, Chrousos GP, Loriaux DL, Barnes K, Munson P, Nieman L, Schaison G.
    J Clin Endocrinol Metab; 1988 Feb 01; 66(2):290-3. PubMed ID: 2828406
    [Abstract] [Full Text] [Related]

  • 40. Comparison of adrenocorticotropin (ACTH) stimulation tests and insulin hypoglycemia in normal humans: low dose, standard high dose, and 8-hour ACTH-(1-24) infusion tests.
    Nye EJ, Grice JE, Hockings GI, Strakosch CR, Crosbie GV, Walters MM, Jackson RV.
    J Clin Endocrinol Metab; 1999 Oct 01; 84(10):3648-55. PubMed ID: 10523009
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.